Chris Wood

Chris Wood

Formal First Name
Christopher (Chris)

Chris Wood is a Chief Investment Officer for Healthcare and Biotech at Mauldin Economics, as well as a Chief Investment Officer at RiskHedge, a professional investment research firm focused on understanding and profiting from disruption. With over 16 years of professional experience as a professional investor, author, and tech commentator, Chris is considered as a Health and Biotech Market veteran and one of America’s most respected analysts. Throughout his career, his unique ability to consistently pinpoint stocks that double and triple has intrigued thousands of readers. In addition to his corporate responsibilities, Chris also speaks in investment conferences and evaluates investments on the road.

Professional Experience

Academic History

  • Editor Chris Wood and his professional analysts pinpoint profitable investments in the booming healthcare and anti-aging sectors.
  • He helps you navigate these sectors without using riskier trading tools like options or day trading—and without recommending any dangerously volatile penny stocks.
  • In 2017 alone, Chris booked 100%+ gains on seven different stocks.
  • He studied at Loyola University under top Austrian economist Walter Block.